- 45 minutes 55 secondsCAR T-cells, Interview with Dr Caroline BatemanCAR T-cell therapy is an exciting new treatment for acute leukaemia. In this episode, Dr Geoff interviews his colleague Dr Caroline Bateman about CAR T-cells and introducing the treatment option to her unit.
Hosted on Acast. See acast.com/privacy for more information.
14 March 2022, 1:30 am - 24 minutes 26 seconds"S" is for "Special" : Stage MS Neuroblastoma (also called Stage IVS, 4S)There is a special subtype of neuroblastoma seen in very young children, with spread of disease throughout the body, but which needs a very different approach to treatment compared to older children with metastatic disease. This episode explains the features of this stage MS neuroblastoma, the early problems, and the treatment used.
Hosted on Acast. See acast.com/privacy for more information.
20 May 2021, 5:38 am - 44 minutes 44 secondsWhere did my child's immune system go?Childhood cancer treatment leads to severe impairment of the ability to fight infections. This episode explains what immune suppression means, what causes it, and the problems that result.
Hosted on Acast. See acast.com/privacy for more information.
26 March 2021, 5:01 am - 39 minutes 46 secondsUpdate re the future of rock and roll.... CAR T-cellsA few years ago I described CAR T-cells, but they weren't available for routine use. I now update things, with the very important news about CAR T-cell therapy now becoming available. There is also an interview with Dr Caroline Bateman re this subject in another episode.
Hosted on Acast. See acast.com/privacy for more information.
10 March 2021, 12:24 am - 22 minutes 13 secondsBlood CulturesWe take a lot of blood samples looking for infection in the bloodstream. This episode explains what blood cultures are all about.
Hosted on Acast. See acast.com/privacy for more information.
8 March 2021, 4:49 am - 56 minutes 12 secondsPRISM, Molecular Profiling, and Informed ConsentA number of countries have research studies where childhood cancers are analysed in great detail, testing all the DNA in something called 'molecular profiling'. The national Australian study of this is called PRISM, and it is a very exciting project. This episode explains a molecular profiling project and covers issues of obtaining informed consent from parents and patients as well.
Hosted on Acast. See acast.com/privacy for more information.
24 February 2021, 12:29 am - 41 minutes 14 secondsThe MEK inhibitors: trametinib and selumetinibThe MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis.
Hosted on Acast. See acast.com/privacy for more information.
19 February 2021, 1:42 am - 42 minutes 5 secondsThe needle in the haystack: Minimal Residual DiseaseSophisticated techniques can detect one cancer cell amongst a million normal cells. This episode describes these methods and how they are used in treatment.
Hosted on Acast. See acast.com/privacy for more information.
14 January 2021, 7:29 am - 13 minutes 37 secondsDIPG: to biopsy or not to biopsyFor many years we didn't biopsy the tumour when the scans suggested that the tumour was a DIPG. This episode explains why that has changed, and the emerging role of biopsy.
Hosted on Acast. See acast.com/privacy for more information.
16 November 2020, 4:53 am - 19 minutes 55 secondsDIPG: what do these letters stand for?DIPG is a type of brain tumor which occurs in children. This episode explains what the letters mean.
Hosted on Acast. See acast.com/privacy for more information.
22 January 2017, 11:04 pm - 22 minutes 51 secondsChemotherapy 7: IfosfamideIfosfamide is another chemotherapy drug, used particularly in certain sarcomas and certain patients with leukaemia. This episode explains how it is given, and common and rare side effects.
Hosted on Acast. See acast.com/privacy for more information.
27 November 2016, 11:08 pm - More Episodes? Get the App